Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease-Reference-Cited by-同舟云学术

Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease

Published:2019-02 Issue: Volume:336 Page:12-19
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Geraghty N.J.,Watson D.,Sluyter R.

Funder

University of Wollongong

Publisher

Elsevier BV

Subject

Immunology

Reference49 articles.

1. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

2. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment;Martin;Blood,1990

3. The biology of graft-versus-host reactions;Billingham;Harvey Lect.,1965

4. Immunobiology of acute graft-versus-host disease;Reddy;Blood Rev.,2003

5. Pathophysiology of Graft-Versus-Host Disease;Ferrara;Semin. Hematol.,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice;International Journal of Molecular Sciences;2024-02-01

2. A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice;Pharmaceutics;2023-08-31

3. Purinergic signalling in graft-versus-host disease;Current Opinion in Pharmacology;2023-02

4. ATP ion channel P2X purinergic receptors in inflammation response;Biomedicine & Pharmacotherapy;2023-02

5. Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma;Chemical Biology & Drug Design;2022-11-29